Clinical Trial Update: A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121 [Phase 1]

View source ↗

Summary

Phase 1 trial comparing pharmacokinetics, pharmacodynamics, and safety of two investigational agents, AD-212-A and AD-2121, in gastroesophageal reflux disease. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• AD-212-A
• AD-2121

Snippet

Sponsor: Addpharma Inc. | Conditions: Gastro Esophageal Reflux | Phase 1 | Status: COMPLETED